REGISTERED NUMBER: 05379955 (England and Wales)

C B PHARMACIES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr V Duggal

Mr N Duggal

Mrs B Duggal

REGISTERED OFFICE:

Cash's Business Centre

1st Floor

228 Widdrington Road

Coventry

West Midlands

CV1 4PB

REGISTERED NUMBER:

05379955 (England and Wales)

ACCOUNTANTS:

Shah & Co (Accountants) Ltd

Chartered Certified Accountants

Cash's Business Centre

1st Floor

228 Widdrington Road

Coventry

West Midlands

CV1 4PB

FIXED ASSETS

Intangible assets

4

4,104

53,354

Tangible assets

5

196,511

206,381

200,615

259,735

CURRENT ASSETS

Stocks

156,308

165,787

Debtors

6

412,848

381,337

Cash at bank and in hand

11,506

7,661

580,662

554,785

CREDITORS

Amounts falling due within one year

7

(359,139

)

(395,802

)

NET CURRENT ASSETS

221,523

158,983

TOTAL ASSETS LESS CURRENT LIABILITIES

422,138

418,718

PROVISIONS FOR LIABILITIES

(2,461

)

(2,461

)

NET ASSETS

419,677

416,257

CAPITAL AND RESERVES

Called up share capital

1,000

1,000

Revaluation reserve

8

48,100

48,100

Retained earnings

370,577

367,157

419,677

416,257

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 November 2025 and were signed on its behalf by:

Mr N Duggal - Director

1.	STATUTORY INFORMATION

C B Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2005, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

25% on cost

Motor vehicles

-

25% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 26 (2024 - 28 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2024

and 31 March 2025

985,000

AMORTISATION

At 1 April 2024

931,646

Charge for year

49,250

At 31 March 2025

980,896

NET BOOK VALUE

At 31 March 2025

4,104

At 31 March 2024

53,354

5.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

Plant and

and

Motor

property

machinery

fittings

vehicles

Totals

£

£

£

£

£

COST

At 1 April 2024

and 31 March 2025

271,000

5,998

48,455

14,194

339,647

DEPRECIATION

At 1 April 2024

82,628

4,959

37,626

8,053

133,266

Charge for year

5,420

208

2,707

1,535

9,870

At 31 March 2025

88,048

5,167

40,333

9,588

143,136

NET BOOK VALUE

At 31 March 2025

182,952

831

8,122

4,606

196,511

At 31 March 2024

188,372

1,039

10,829

6,141

206,381

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade debtors

369,520

350,175

Other debtors

43,328

31,162

412,848

381,337

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Bank loans and overdrafts

33,688

2,876

Trade creditors

242,602

369,783

Taxation and social security

37,547

8,746

Other creditors

45,302

14,397

359,139

395,802

8.

RESERVES

Revaluation

reserve

£

At 1 April 2024

and 31 March 2025

48,100

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

Included in other creditor amount outstanding to Mr N Duggal is nil (2023: £5,512.) Amount is interest free with no set terms of repayment.

10.	ULTIMATE CONTROLLING PARTY

The controlling party is Duggal Holdings Limited..

The ultimate controlling parties are Mrs Bholi Duggal, Mr Nitin Duggal and Mr Vipin Duggal by virtue of their majority shareholding in the parent company, Duggal Holdings Limited.